Pulse Biosciences (PLSE) Cash & Equivalents Growth (5y) (2020 - 2025)
Pulse Biosciences (PLSE) Cash & Equivalents Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Pulse Biosciences | 2.23 Bn | 2.15 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 68.21% |
| Jun 30, 2025 | 23.01% |
| Mar 31, 2025 | 72.26% |
| Dec 31, 2024 | 76.46% |
| Sep 30, 2024 | 52.54% |
| Jun 30, 2024 | 19.43% |
| Mar 31, 2024 | 32.53% |
| Dec 31, 2023 | -2.79% |
| Sep 30, 2023 | 51.41% |
| Jun 30, 2023 | 52.69% |
| Mar 31, 2023 | 38.37% |
| Dec 31, 2022 | 76.48% |
| Sep 30, 2022 | 16.36% |
| Jun 30, 2022 | 49.37% |
| Mar 31, 2022 | 35.74% |
| Dec 31, 2021 | 84.26% |
| Sep 30, 2021 | 55.44% |
| Jun 30, 2021 | 18.60% |
| Mar 31, 2021 | 95.35% |
| Sep 30, 2020 | 7.39% |